Fig. 5From: Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression typesReceiver operating characteristic (ROC) analysis. ROC analysis showed that the results for “high-ALC and PPL” (area under the curve (AUC): 0.666) were better than those for the ALC (AUC: 0.639), “low-ALC and PPL” (AUC: 0.455), “high-ALC and PNM” (AUC: 0.473), and “low-ALC and PNM” (AUC: 0.406)Back to article page